Soluble Suppression of Tumorigenicity-2 (sst2) Predicts Mortality and Right Heart Failure in Lvad Patients

被引：0
|
作者：
Numan, L. [1 ]
Aarts, E. [2 ]
Ramjankhan, F. [3 ]
Van der Meer, M. G. [1 ]
Oerlemans, M. [4 ]
De Jonge, N. [1 ]
Oppelaar, A. [3 ]
Kemperman, H. [5 ]
Asselbergs, F. [4 ]
Van Laake, L. W. [1 ]
机构：
[1] Univ Med Ctr Utrecht, Cardiol, Utrecht, Netherlands
[2] Univ Utrecht, Methodol Stat, Utrecht, Netherlands
[3] Univ Med Ctr Utrecht, Cardiothorac Surg, Utrecht, Netherlands
[4] Univ Med Ctr Utrecht, Cardiol, Utrecht, Netherlands
[5] Univ Med Ctr Utrecht, Cent Diagnost Lab, Utrecht, Netherlands
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2023年 / 42卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
834
引用
收藏
页码：S364 / S365
页数：2
相关论文
共 50 条
  • [31] Diagnostic and Prognostic Values of Soluble Suppression of Tumorigenicity-2 Measurements in the Treatment Assessment of Adult Patients with Congenital Heart Disease and Cardiac Failure
    Khajali, Zahra
    Firouzi, Ata
    Arabian, Maedeh
    Naderi, Nasim
    Maleki, Majid
    Saedi, Sedigheh
    Aliramezany, Maryam
    INTERNATIONAL CARDIOVASCULAR RESEARCH JOURNAL, 2020, 14 (04) : 127 - 131
  • [32] Soluble suppression of tumorigenicity 2 (sST2) for predicting disease severity or mortality outcomes in cardiovascular diseases: A systematic review and meta-analysis
    Ip, Christina
    Luk, King Sum
    Yuen, Vincent Lok Cheung
    Chiang, Lorraine
    Chan, Ching Ki
    Ho, Kevin
    Gong, Mengqi
    Lee, Teddy Tai Loy
    Leung, Keith Sai Kit
    Roever, Leonardo
    Bazoukis, George
    Lampropoulos, Konstantinos
    Li, Ka Hou Christien
    Tse, Gary
    Liu, Tong
    IJC HEART & VASCULATURE, 2021, 37
  • [33] Plasma Soluble Suppression of Tumorigenicity-2 Associates with Ventilator Liberation in Acute Hypoxemic Respiratory Failure
    Alladina, Jehan
    Levy, Sean D.
    Cho, Josalyn L.
    Brait, Kelsey L.
    Rao, Sowmya R.
    Camacho, Alexander
    Hibbert, Kathryn A.
    Harris, R. Scott
    Medoff, Benjamin D.
    Januzzi, James L.
    Thompson, B. Taylor
    Bajwa, Ednan K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (10) : 1257 - 1265
  • [34] Serum Cardiac Biomarkers in Asymptomatic Hemodialysis Patients: Role of Soluble Suppression of Tumorigenicity-2
    Mancianti, Nicoletta
    Maresca, Barbara
    Palladino, Marco
    Salerno, Gerardo
    Cardelli, Patrizia
    Mene, Paolo
    Barberi, Simona
    BLOOD PURIFICATION, 2022, 51 (02) : 155 - 162
  • [35] Soluble form of suppression of tumorigenicity-2 predicts clinical stability of inpatients with community-acquired pneumonia
    Zeng, Yifeng
    Xue, Mingshan
    Zhang, Teng
    Sun, Shixue
    Lin, Runpei
    Li, Ning
    Zheng, Peiyan
    Zhen, Yingjie
    Hu, Haisheng
    Zhang, Xiaohua Douglas
    Sun, Baoqing
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2021, 246 (21) : 2297 - 2306
  • [36] Prognostic value of sST2 in heart failure patients with diabetes
    Castiglione, V.
    Chiriaco', M.
    Aimo, A.
    Januzzi, J.
    Richards, A. M.
    Lam, C. S. P.
    Latini, R.
    Anand, I. S.
    Ueland, T.
    Brunner-La Rocca, H. P.
    Bayes-Genis, A.
    De Boer, R. A.
    Huber, K.
    Emdin, M.
    Vergaro, G.
    EUROPEAN HEART JOURNAL, 2021, 42 : 869 - 869
  • [37] Prognostic value of sST2 in heart failure patients with diabetes
    Castiglione, V.
    Chiriaco, M.
    Aimo, A.
    Januzzi, J.
    Richards, A. M.
    Lam, C. S. P.
    Latini, R.
    Anand, I. S.
    Ueland, T.
    Brunner-La Rocca, H. P.
    Bayes-Genis, A.
    De Boer, R. A.
    Huber, K.
    Emdin, M.
    Vergaro, G.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 101 - 102
  • [38] Soluble suppression of tumorigenicity-2 in cardiac amyloidosis, hypertrophic and dilated cardiomyopathy
    Castiglione, V.
    Ghionzoli, N.
    Aimo, A.
    Teresi, L.
    Prontera, C.
    Masotti, S.
    Grigoratos, C.
    Genovesi, D.
    Barison, A.
    Todiere, G.
    Aquaro, G. D.
    Passino, C.
    Emdin, M.
    Vergaro, G.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 498 - 498
  • [39] Prognostic Value of sST2 in Heart Failure
    Sciatti, Edoardo
    Merlo, Anna
    Scangiuzzi, Claudio
    Limonta, Raul
    Gori, Mauro
    D'Elia, Emilia
    Aimo, Alberto
    Vergaro, Giuseppe
    Emdin, Michele
    Senni, Michele
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (12)
  • [40] Suppression of tumorigenicity-2 (ST2) is a promising biomarker in heart transplantation
    Galeone, Antonella
    Salem, Joe-Elie
    Lebreton, Guillaume
    Coutance, Guillaume
    Nguyen, Lee
    Hulot, Jean Sebastien
    Atassi, Fabrice
    Bega, Marco
    Leprince, Pascal
    Varnous, Shaida
    CLINICAL TRANSPLANTATION, 2022, 36 (05)
12345